ZYBT
NASDAQ · Pharmaceuticals
Zhengye Biotechnology Holdin
$0.95
-0.03 (-2.87%)
Open$0.98
Previous Close$0.98
Day High$0.98
Day Low$0.94
52W High$13.79
52W Low$0.68
Volume—
Avg Volume82.0K
Market Cap48.37M
P/E Ratio—
EPS$-0.21
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 207.67M | 12.11M | 10.68M |
| Net Income | 12.61M | 2.69M | 1.92M |
| Profit Margin | 6.1% | 22.3% | 18.0% |
| EBITDA | 46.46M | 3.66M | 3.67M |
| Free Cash Flow | — | 1.61M | 1.47M |
| Rev Growth | +854.8% | -0.1% | -5.4% |
| Debt/Equity | 0.30 | 0.37 | 0.43 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |